Hershberger Michael D 4
4 · Health Insurance Innovations, Inc. · Filed Sep 5, 2017
Insider Transaction Report
Form 4
Hershberger Michael D
Chief Financial Officer
Transactions
- Sale
Class A Common Stock
2017-08-31$34.81/sh−2,500$87,017→ 94,569 total - Sale
Class A Common Stock
2017-09-01$33.74/sh−400$13,495→ 89,569 total - Exercise/Conversion
Class A Common Stock
2017-09-01$10.45/sh+15,000$156,750→ 104,569 total - Exercise/Conversion
Class A Common Stock
2017-09-01$4.99/sh+7,500$37,425→ 112,156 total - Disposition to Issuer
Class A Common Stock
2017-09-01$33.81/sh−1,113$37,631→ 111,043 total - Sale
Class A Common Stock
2017-09-01$33.81/sh−2,222$75,126→ 108,821 total - Sale
Class A Common Stock
2017-09-01$30.45/sh−100$3,045→ 90,769 total - Disposition to Issuer
Class A Common Stock
2017-09-01$28.96/sh−4,659$134,948→ 99,910 total - Sale
Class A Common Stock
2017-09-01$28.96/sh−3,597$104,187→ 96,313 total - Disposition to Issuer
Class A Common Stock
2017-09-01$32.02/sh−2,207$70,660→ 109,106 total - Exercise/Conversion
Stock Appreciation Rights
2017-09-01−15,000→ 10,000 totalExercise: $10.45Exp: 2021-05-21→ Common Stock (15,000 underlying) - Exercise/Conversion
Stock Appreciation Rights
2017-09-01−15,000→ 15,000 totalExercise: $4.95Exp: 2022-07-01→ Common Stock (15,000 underlying) - Sale
Class A Common Stock
2017-09-01$28.36/sh−400$11,345→ 94,169 total - Sale
Class A Common Stock
2017-09-01$29.10/sh−3,300$96,027→ 90,869 total - Sale
Class A Common Stock
2017-09-01$32.09/sh−800$25,670→ 89,969 total - Exercise/Conversion
Class A Common Stock
2017-09-01$4.95/sh+15,000$74,250→ 111,313 total - Sale
Class A Common Stock
2017-09-01$32.02/sh−4,450$142,473→ 104,656 total - Exercise/Conversion
Stock Appreciation Rights
2017-09-01−7,500→ 22,500 totalExercise: $4.99Exp: 2022-09-16→ Common Stock (7,500 underlying)
Holdings
- 40,972
Stock Appreciation RIghts
Exercise: $5.20Exp: 2023-09-16→ Common Stock (40,972 underlying)
Footnotes (12)
- [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.75 to $34.90, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations Inc. (the "Company"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F10]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.00 to $32.15, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F11]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.80 to $33.90, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F12]Shares retained by the issuer to satisfy the exercise price of stock appreciation rights exercised by the reporting person.
- [F2]Sale made pursuant to 10b5-1 plan executed on November 18, 2016.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.85 to $28.70, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.00 to $29.0990, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.90 to $32.85, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F6]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.65 to $33.80, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F7]These stock-settled stock appreciation rights were granted under the Long Term Incentive Plan of Health Insurance Innovations, Inc. (the "Plan") and vest 20% on the first three anniversaries of grant date and 40% on the fourth anniversary, subject to the terms of the Plan and an award agreement under the Plan.
- [F8]These stock-settled stock appreciation rights were granted under the Plan and vest 25% on the first and second anniversaries of grant date and 50% on the third anniversary, subject to the terms of the Plan and an award agreement under the Plan.
- [F9]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.90 to $29.00, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.